Page last updated: 2024-08-25

tyrosine methyl ester and Leishmaniasis

tyrosine methyl ester has been researched along with Leishmaniasis in 1 studies

*Leishmaniasis: A disease caused by any of a number of species of protozoa in the genus LEISHMANIA. There are four major clinical types of this infection: cutaneous (Old and New World) (LEISHMANIASIS, CUTANEOUS), diffuse cutaneous (LEISHMANIASIS, DIFFUSE CUTANEOUS), mucocutaneous (LEISHMANIASIS, MUCOCUTANEOUS), and visceral (LEISHMANIASIS, VISCERAL). [MeSH]

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Arora, SK; Garg, P; Jain, SK; Kaur, A; Kumar, R; Sharma, SS; Singh, IP; Singh, S1

Other Studies

1 other study(ies) available for tyrosine methyl ester and Leishmaniasis

ArticleYear
Synthesis and antileishmanial activity of piperoyl-amino acid conjugates.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:8

    Topics: Alkaloids; Amino Acids; Animals; Antiprotozoal Agents; Benzodioxoles; Catalytic Domain; Cricetinae; Esters; Humans; Inhibitory Concentration 50; Leishmania donovani; Leishmaniasis; Male; Models, Molecular; Piperidines; Polyunsaturated Alkamides

2010
chemdatabank.com